文献速递糖尿病

荷兰南亚裔与荷兰欧洲裔2型糖尿病患者炎症通路的差异

Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

本研究对两项随机对照试验进行二次分析,比较荷兰南亚裔(n=45)与荷兰欧洲裔(n=44)2型糖尿病患者空腹全血中182个免疫基因的mRNA表达。南亚裔患者B细胞标志物和干扰素信号基因表达更高,干扰素信号通路为最显著通路,且该差异在女性中更明显。作者推测干扰素信号通路激活可能 contribute 于南亚裔2型糖尿病进展更快。

要点

  • 南亚裔2型糖尿病患者B细胞标志物mRNA水平高于欧洲裔(倍数变化>1.3,FDR<0.008)。
  • 南亚裔干扰素信号基因表达升高(倍数变化>1.2,FDR<0.05),血浆IFN-γ水平更高(倍数变化=1.5,FDR=0.01)。
  • 基因表达差异在女性中更明显(女性20/182 [11%] vs 男性2/182 [1%])。

核心结论

  • 南亚裔2型糖尿病患者较欧洲裔患者显示更活化的干扰素信号通路,且该差异在女性中比男性更明显。
  • 作者推测更活化的干扰素信号通路可能 contribute 于南亚裔较欧洲裔个体2型糖尿病进展更快。

研究设计与样本

  • 对两项随机对照试验进行二次分析,纳入荷兰南亚裔2型糖尿病患者45例(年龄55±10岁,BMI 29±4 kg/m2)和荷兰欧洲裔2型糖尿病患者44例(年龄60±7岁,BMI 32±4 kg/m2)。
  • 主要结局指标为空腹全血中182个免疫基因的mRNA转录本(微流控定量聚合酶链反应;Fluidigm Inc)及 ingenuity 通路分析(Qiagen)。

主要发现

  • 南亚裔较欧洲裔B细胞标志物mRNA水平更高(CD19、CD79A、CD79B、CR2、CXCR5、IGHD、MS4A1、PAX5;所有倍数变化>1.3,FDR<0.008)。
  • 南亚裔较欧洲裔干扰素信号基因mRNA水平更高(CD274、GBP1、GBP2、GBP5、FCGR1A/B/CP、IFI16、IFIT3、IFITM1、IFITM3、TAP1;所有倍数变化>1.2,FDR<0.05)。
  • 南亚裔中干扰素信号通路为最显著经典通路(z评分2.6;P<.001),并伴随血浆IFN-γ水平更高(倍数变化=1.5,FDR=0.01)。
  • 基因表达的种族差异在女性中更大(女性20/182 [11%]) than 男性(2/182 [1%])。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: South Asian individuals are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians. OBJECTIVE: This work aimed to study whether circulating messenger RNA (mRNA) transcripts of immune genes are different between South Asian compared with Europid patients with T2D. METHODS: A secondary analysis was conducted of 2 randomized controlled trials of Dutch South Asian (n = 45; age: 55 ± 10 years, body mass index [BMI]: 29 ± 4 kg/m2) and Dutch Europid (n = 44; age: 60 ± 7 years, BMI: 32 ± 4 kg/m2) patients with T2D. Main outcome measures included mRNA transcripts of 182 immune genes (microfluidic quantitative polymerase chain reaction; Fluidigm Inc) in fasted whole-blood, ingenuity pathway analyses (Qiagen). RESULTS: South Asians, compared to Europids, had higher mRNA levels of B-cell markers (CD19, CD79A, CD79B, CR2, CXCR5, IGHD, MS4A1, PAX5; all fold change > 1.3, false discovery rate [FDR] < 0.008) and interferon (IFN)-signaling genes (CD274, GBP1, GBP2, GBP5, FCGR1A/B/CP, IFI16, IFIT3, IFITM1, IFITM3, TAP1; all FC > 1.2, FDR < 0.05). In South Asians, the IFN signaling pathway was the top canonical pathway (z score 2.6; P < .001) and this was accompanied by higher plasma IFN-γ levels (FC = 1.5, FDR = 0.01). Notably, the ethnic difference in gene expression was larger for women (20/182 [11%]) than men (2/182 [1%]). CONCLUSION: South Asian patients with T2D show a more activated IFN-signaling pathway compared to Europid patients with T2D, which is more pronounced in women than men. We speculate that a more activated IFN-signaling pathway may contribute to the more rapid progression of T2D in South Asian compared with Europid individuals.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Straat ME, Martinez-Tellez B, van Eyk HJ, et al. Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes. J Clin Endocrinol Metab. 2023. PMID: 36262060. doi:10.1210/clinem/dgac598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。